SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-23-007964
Filing Date
2023-11-13
Accepted
2023-11-13 13:51:01
Documents
17
Period of Report
2023-11-06
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cannapharmarx_8k.htm   iXBRL 8-K 32742
2 LETTER FROM BF BORGERS CPA PC, DATED NOVEMBER 13, 2023 cannapharmarx_ex0901.htm EX-9.01 4771
3 ENGAGEMENT LETTER WITH GREENGROWTH CPAS DATED NOVEMBER 3, 2023 cannapharmarx_ex0902.htm EX-9.02 51129
7 GRAPHIC image_006.jpg GRAPHIC 2858
8 GRAPHIC image_007.jpg GRAPHIC 2858
9 GRAPHIC image_008.jpg GRAPHIC 9054
  Complete submission text file 0001683168-23-007964.txt   300211

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cpmd-20231106.xsd EX-101.SCH 3030
5 XBRL LABEL FILE cpmd-20231106_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE cpmd-20231106_pre.xml EX-101.PRE 22369
11 EXTRACTED XBRL INSTANCE DOCUMENT cannapharmarx_8k_htm.xml XML 3414
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27055 | Film No.: 231397487
SIC: 2834 Pharmaceutical Preparations